Published: Guidance, quality standards and advice

Skip to filters Skip to results

Showing 1 to 7 of 7

Sort by

Last updated date between: 1/6/2018 and 30/6/2018Remove Last updated date between: 1/6/2018 and 30/6/2018 filter
Type: GuidanceRemove Type: Guidance filter
Type: NICE adviceRemove Type: NICE advice filter
Type: Quality standardRemove Type: Quality standard filter
Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter
Guidance programme: Antimicrobial prescribing guidelinesRemove Guidance programme: Antimicrobial prescribing guidelines filter
Guidance programme: Cancer service guidelinesRemove Guidance programme: Cancer service guidelines filter
Guidance programme: Diagnostics guidanceRemove Guidance programme: Diagnostics guidance filter
Guidance programme: Highly specialised technologies guidanceRemove Guidance programme: Highly specialised technologies guidance filter
Guidance programme: Interventional procedures guidanceRemove Guidance programme: Interventional procedures guidance filter
Guidance programme: Medical technologies guidanceRemove Guidance programme: Medical technologies guidance filter
Guidance programme: Medicines practice guidelinesRemove Guidance programme: Medicines practice guidelines filter
Guidance programme: Public health guidelinesRemove Guidance programme: Public health guidelines filter
Guidance programme: Safe staffing guidelinesRemove Guidance programme: Safe staffing guidelines filter

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Beta interferons and glatiramer acetate for treating multiple sclerosis	TA527	27 June 2018	27 June 2018
Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease	TA217	23 March 2011	20 June 2018
Arsenic trioxide for treating acute promyelocytic leukaemia	TA526	13 June 2018	13 June 2018
Guselkumab for treating moderate to severe plaque psoriasis	TA521	13 June 2018	13 June 2018
Midostaurin for untreated acute myeloid leukaemia	TA523	13 June 2018	13 June 2018
Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma	TA524	13 June 2018	13 June 2018
Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy	TA525	13 June 2018	13 June 2018

Results per page

10
25
50
All